(Q40519209)

21 September 2017

1 reference

title

Vasculitis associated with antiphospholipid syndrome (English)

1 reference

21 September 2017

Norden DK

1

1 reference

21 September 2017

Ostrov BE

series ordinal

2

1 reference

21 September 2017

Shafritz AB

series ordinal

3

1 reference

21 September 2017

Von Feldt JM

series ordinal

4

1 reference

21 September 2017

language of work or name

1 reference

1 February 1995

1 reference

Seminars in Arthritis and Rheumatism

21 September 2017

published in

1 reference

21 September 2017

volume

24

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

273-281

1 reference

Antiphospholipid antibody syndrome: immunologic and clinical aspects

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Recurrent Arterial Thrombosis in a Patient with Giant-cell Arteritis and Raised Anticardiolipin Antibody Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Anti-phospholipid antibodies and ischaemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Anticardiolipin antibodies: occurrence in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Syndrome of the black swan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Lupus and antiphospholipid antibody syndrome: either, neither, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Polyarteritis nodosa: A clinical and angiographic analysis of 17 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Fluorescein angiography in the diagnosis of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Anticardiolipin antibodies in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Anticardiolipin antibodies in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

Anticardiolipin response in acute infections

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980037-9

7 January 2021

10.1016/S0049-0172(95)80037-9

Identifiers

DOI

1 reference

21 September 2017

1 reference